Status: Not yet recruiting
Study Interchangeability Hep-B Vaccine Administered at Birth Dose
This trial is a randomized, double-blind, two arms parallel groups, prospective intervention study.
Participants needed: 270
Trial details
Phase: Phase 3Age: 0-3Biological sex: AllType: InterventionalSponsor: PT Bio FarmaUpdated: Oct 2, 2026
Eligibility criteria
Healthy, full term, newborn infants. [+4]
Infants concomitantly enrolled or scheduled to be enrolled in another trial. [+6]